New Lyme disease vaccine targets decades of anti-vax misinformation – New Atlas
A new Lyme disease vaccine is about to enter its final phase of human trialling. If all goes well it could be available by 2025, making it the first vaccine for Lyme disease to reach the market in nearly a quarter of a century. The Phase 3 clinical trial plans to enroll at least 6,000 participants …
Read More